133 related articles for article (PubMed ID: 26565742)
1. False-positive hepatitis C virus serology after placement of a ventricular assistance device.
Durand CM; Marr KA; Ostrander D; Subramanian A; Valsamakis A; Cox A; Neofytos D
Transpl Infect Dis; 2016 Feb; 18(1):146-9. PubMed ID: 26565742
[TBL] [Abstract][Full Text] [Related]
2. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
[TBL] [Abstract][Full Text] [Related]
3. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.
Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J
Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818
[TBL] [Abstract][Full Text] [Related]
4. Characterization of differential antibody production against hepatitis C virus in different HCV infection status.
Rafik M; Bakr S; Soliman D; Mohammed N; Ragab D; ElHady WA; Samir N
Virol J; 2016 Jun; 13():116. PubMed ID: 27357382
[TBL] [Abstract][Full Text] [Related]
5. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
Pereira FM; Zarife MA; Reis EA; G Reis M
Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
[TBL] [Abstract][Full Text] [Related]
6. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors.
Cavazza S; Lagging M
Scand J Infect Dis; 2005; 37(6-7):488-92. PubMed ID: 16012009
[TBL] [Abstract][Full Text] [Related]
7. HCV false positive immunoassays in patients with LVAD: A potential trap!
Heinrichs A; Antoine M; Steensels D; Montesinos I; Delforge ML
J Clin Virol; 2016 May; 78():44-6. PubMed ID: 26985592
[TBL] [Abstract][Full Text] [Related]
8. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection.
Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937
[TBL] [Abstract][Full Text] [Related]
10. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody.
Dussaix E; Charnaux N; Laurent-Puig P; Chopineau S; Laurian Y; Buffet C
J Clin Microbiol; 1994 Sep; 32(9):2071-5. PubMed ID: 7529247
[TBL] [Abstract][Full Text] [Related]
11. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study.
Chasela CS; Wall P; Drobeniuc J; King CC; Teshale E; Hosseinipour MC; Ellington SR; Codd M; Jamieson DJ; Knight RJ; Fitzpatrick P; Kourtis AP; Hoffman IF; Kayira D; Mumba N; Kamwendo DD; Martinson F; Powderly W; van der Horst C; Kamili S;
J Clin Virol; 2012 Aug; 54(4):318-20. PubMed ID: 22658797
[TBL] [Abstract][Full Text] [Related]
13. The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling.
Makuria AT; Raghuraman S; Burbelo PD; Cantilena CC; Allison RD; Gibble J; Rehermann B; Alter HJ
Transfusion; 2012 Sep; 52(9):1940-8. PubMed ID: 22304422
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay.
Zanella A; Conte D; Prati D; Mozzi F; Capelli C; Zanuso F; Fraquelli M; Bosoni P; Vianello L; Pappalettera M
Hepatology; 1995 Apr; 21(4):913-7. PubMed ID: 7535737
[TBL] [Abstract][Full Text] [Related]
15. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
[TBL] [Abstract][Full Text] [Related]
16. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
[TBL] [Abstract][Full Text] [Related]
17. Study on reliability of commercially available hepatitis C virus antibody tests.
Feucht HH; Zöllner B; Polywka S; Laufs R
J Clin Microbiol; 1995 Mar; 33(3):620-4. PubMed ID: 7751366
[TBL] [Abstract][Full Text] [Related]
18. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
Bruhn R; Lelie N; Busch M; Kleinman S;
Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
[TBL] [Abstract][Full Text] [Related]
19. Efficiency of the ortho VITROS assay for detection of hepatitis C virus-specific antibodies increased by elimination of supplemental testing of samples with very low sample-to-cutoff ratios.
Oethinger M; Mayo DR; Falcone J; Barua PK; Griffith BP
J Clin Microbiol; 2005 May; 43(5):2477-80. PubMed ID: 15872288
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of false-positive hepatitis C antibody results, National Health and Nutrition Examination Study (NHANES) 2007-2012.
Moorman AC; Drobenuic J; Kamili S
J Clin Virol; 2017 Apr; 89():1-4. PubMed ID: 28171829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
